Sequential administration of varying doses of dacarbazine and fotemustine in advanced malignant melanoma
about
Marked inactivation of O6-alkylguanine-DNA alkyltransferase activity with protracted temozolomide schedulesA phase I/II study of lomustine and temozolomide in patients with cerebral metastases from malignant melanomaTemozolomide in combination with fotemustine in patients with metastatic melanoma.Inactivation of O6-alkylguanine-DNA alkyltransferase in human peripheral blood mononuclear cells by temozolomide.The therapeutic potential of O6-alkylguanine DNA alkyltransferase inhibitors.O(6)-methylguanine-DNA methyltransferase depletion and DNA damage in patients with melanoma treated with temozolomide alone or with lomeguatribFotemustine for the treatment of melanoma.The P140K mutant of human O(6)-methylguanine-DNA-methyltransferase (MGMT) confers resistance in vitro and in vivo to temozolomide in combination with the novel MGMT inactivator O(6)-(4-bromothenyl)guanine.Systemic therapy of malignant melanoma.Differential inactivation of mammalian and Escherichia coli O6-alkylguanine-DNA alkyltransferases by O6-benzylguanine.Effect of O6-(4-bromothenyl)guanine on different temozolomide schedules in a human melanoma xenograft model.DNA repair enzymes and cytotoxic effects of temozolomide: comparative studies between tumor cells and normal cells of the immune system.O(6)-(4-bromothenyl)guanine improves the therapeutic index of temozolomide against A375M melanoma xenografts.
P2860
Q33347264-8A4BF13C-A2ED-4D65-A63F-14A73BDF68A2Q33373492-1C5A1783-3A1A-49A4-95C2-B1E35AF3B47CQ33376875-3D3ED39A-C176-4BFC-BECC-9774F05FEDB3Q35978302-7AE095C2-7225-4724-99C4-F9100145D9A0Q36964700-11CBA868-0990-4635-93AE-7D4EC4A6861BQ37177925-9D0EBE8C-EAD7-4B77-9832-3DC3D5E41904Q37955277-34CDB590-DF72-46F8-8096-3CC74F90DEE9Q40390060-87E49D95-B0A3-41F3-818A-52982C8899D4Q41611822-88D9BEFC-E4FE-41B2-9713-45633E9A3E08Q42046696-37757ADE-E8DE-4722-AB16-CD9D85041A2BQ44068912-E99FC217-E08D-4D27-B094-CD7EE6F628FCQ44471917-42DA202F-AD53-4CBC-BDE1-FA489EDB4986Q53414888-4B3CA5E4-BC2B-484A-95E7-49BE8B5C9744
P2860
Sequential administration of varying doses of dacarbazine and fotemustine in advanced malignant melanoma
description
1993 nî lūn-bûn
@nan
1993 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1993 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1993年の論文
@ja
1993年学术文章
@wuu
1993年学术文章
@zh-cn
1993年学术文章
@zh-hans
1993年学术文章
@zh-my
1993年学术文章
@zh-sg
1993年學術文章
@yue
name
Sequential administration of v ...... in advanced malignant melanoma
@ast
Sequential administration of v ...... in advanced malignant melanoma
@en
type
label
Sequential administration of v ...... in advanced malignant melanoma
@ast
Sequential administration of v ...... in advanced malignant melanoma
@en
prefLabel
Sequential administration of v ...... in advanced malignant melanoma
@ast
Sequential administration of v ...... in advanced malignant melanoma
@en
P2093
P2860
P356
P1476
Sequential administration of v ...... in advanced malignant melanoma
@en
P2093
P2860
P2888
P304
P356
10.1038/BJC.1993.251
P407
P577
1993-06-01T00:00:00Z
P5875
P6179
1046797198